U.S. Physical Therapy, Inc. (USPH)

Precedente Chiudi:

$101.56

Aprire:

$102.4

Volume 24 ore:

48,861

Capitalizzazione di mercato:

$1.56B

Reddito:

$604.80M

Utile/perdita netta:

$14.67M

Rapporto P/E:

53.70

EPS:

1.93

Flusso di cassa netto:

$72.68M

1 W Prestazione:

+3.25%

1M Prestazione:

-3.32%

6M Prestazione:

+24.36%

1 anno Prestazione:

-0.13%

Intervallo 1D:

$101.86

$103.73

Portata 52W:

$78.08

$124.11

U.S. Physical Therapy, Inc. Stock (USPH) Company Profile

Nome

U.S. Physical Therapy, Inc.

Settore

Healthcare (1210)

Industria

Medical Care Facilities (57)

Telefono

713-297-7000

Indirizzo

1300 West Sam Houston Parkway South, Suite 300, Houston, TX

Dipendente

3,000

Cinguettio

@usphystherapy

Prossima data di guadagno

2024-05-08

Ultimi documenti SEC

USPH's Discussions on Twitter

U.S. Physical Therapy, Inc. Stock (USPH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-09-22	Iniziato	JP Morgan	Overweight
2023-06-30	Iniziato	BofA Securities	Buy
2021-12-14	Aggiornamento	CJS Securities	Market Perform → Market Outperform
2021-08-06	Reiterato	Barrington Research	Outperform
2021-05-07	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2021-05-03	Aggiornamento	Jefferies	Hold → Buy
2021-02-26	Downgrade	Barrington Research	Outperform → Mkt Perform
2020-06-08	Reiterato	Barrington Research	Outperform
2020-04-30	Downgrade	Sidoti	Buy → Neutral
2020-03-11	Aggiornamento	Sidoti	Neutral → Buy
2020-02-28	Reiterato	Barrington Research	Outperform
2019-11-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2019-03-08	Iniziato	William Blair	Outperform
2017-11-03	Downgrade	Barrington Research	Outperform → Mkt Perform
2017-09-08	Aggiornamento	Sidoti	Neutral → Buy
2017-07-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2017-03-17	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-11-04	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2016-08-05	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-05-06	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2016-03-01	Downgrade	Jefferies	Buy → Hold
2015-11-06	Downgrade	Barrington Research	Outperform → Mkt Perform
2015-05-06	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2013-12-12	Reiterato	Dougherty & Company	Buy
2013-08-23	Reiterato	Dougherty & Company	Buy
2013-01-14	Reiterato	Dougherty & Company	Buy
2010-07-09	Iniziato	JMP Securities	Mkt Outperform

Mostra tutto

U.S. Physical Therapy, Inc. Borsa (USPH) Ultime notizie

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Investment Research

ADUS vs. USPH: Which Stock Should Value Investors Buy Now?

Zacks Investment Research

ADUS or USPH: Which Is the Better Value Stock Right Now?

Zacks Investment Research

U.S. Physical Therapy (USPH) Tops Q4 Earnings and Revenue Estimates

Zacks Investment Research

Chemed (CHE) Tops Q4 Earnings Estimates

Zacks Investment Research

AMED vs. USPH: Which Stock Is the Better Value Option?

Zacks Investment Research

U.S. Physical Therapy, Inc. Azioni (USPH) Dati Finanziari

U.S. Physical Therapy, Inc. (USPH) Reddito 2024

U.S. Physical Therapy, Inc. (USPH) Reddito netto 2024

U.S. Physical Therapy, Inc. (USPH) Flusso di cassa 2024

U.S. Physical Therapy, Inc. (USPH) Utile per azione 2024